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C A S E
R E P O R T
Introduction
Colon carcinoma with liver metastasis is a well rec-
ognized entity that is usually diagnosed by com-
puted tomography (CT) or sonography. Although
echograms display the broadest spectrum of me-
tastatic appearance of all the imaging modalities
employed, there may be a wide range of different
echo patterns. We recently experienced a case of
liver metastasis from colon carcinoma mimicking
infiltrating hepatoma with portal vein thrombosis
based on abdominal ultrasonography and enhan-
ced CT studies.
Case Report
An 80-year-old woman with chronic hepatitis C
was referred to us from a local medical depart-
ment on September 17, 2005 with ascending
colon carcinoma and severe anemia. Metastatic
liver tumor (Fig. 1) was not detected on CT scan-
ning. Right hemicolectomy was performed on
September 23, 2005 in our Department of Surgery.
The final diagnosis was cecal carcinoma Dukes’
stage C2. After her return home, she was lost to
follow-up. However, she visited our hospital again
on February 6, 2006, owing to the passage of tarry
A Case of Liver Metastasis From Colon
Cancer Mimicking Infiltrating Hepatoma With
Portal Vein Thrombosis
Yao-Kang Huang, Kui-Lin Cheng*, Chung-Shi Wang
Colon carcinoma with liver metastasis is a well recognized entity. However, it occasionally
creates some difficulties in making the correct diagnosis. We recently experienced a case
of liver metastasis from colon cancer that appeared as infiltrating hepatoma with portal
vein thrombosis on abdominal ultrasonography and enhanced computed tomography
(CT). This diagnosis was confirmed by CT-guided needle biopsy. Consequently, liver
metastasis from colon carcinoma can be misdiagnosed as infiltrating hepatoma with portal
vein thrombosis on the basis of abdominal ultrasonography and even enhanced CT scans.
To obtain a correct diagnosis, particularly in patients with inconsistent clinical presentations,
CT scans or ultrasonographic guided needle biopsy should be mandatory.
KEY WORDS — abdominal ultrasonography, enhanced CT scans, infiltrating
hepatoma, liver metastasis
■ J Med Ultrasound 2009;17(4):212–217 ■
Received: January 17, 2009 Accepted: April 13, 2009
Division of Gastroenterology, Department of Internal Medicine, Chung-Li Ten Chen General Hospital,
Chung-Li, Taoyuan County, Taiwan.
*Address correspondence to: Dr. Kui-Lin Cheng, Department of Radiology, Chung-Li Cheng General Hospital,
155 Yan-Ping Road, Chung-Li, Taoyuan County 320, Taiwan. E-mail: radcheng@tcmg.com.tw
Liver Metastasis Mimicking Infiltrating Hepatoma
213J Med Ultrasound 2009 • Vol 17 • No 4
stools, hematemesis, general malaise and dizziness
for 2 days. Upon admission, the patient had been
chronically ill. Pale skin and anemic conjunctiva
were noted. Physical examinations of her heart
and chest were normal, but palpation of the liver
revealed pronounced hepatomegaly. A full blood
count on admission showed anemia with a hemo-
globin of 8.0 g/dL. Serum aspartate aminotrans-
ferase and alanine aminotransferase levels were
2.37 μkat/L and 0.84 μkat/L, respectively. The carci-
noembryonic antigen (CEA) level was 1,412 ng/mL
whereas alpha-fetoprotein (AFP) level was 2.1ng/mL.
Chest X-ray showed no evidence of pulmonary meta-
stasis, while upper gastrointestinal panendoscopy
revealed duodenal ulcer with no esophageal or
gastric varices.
Abdominal ultrasonography demonstrated a
remarkably enlarged liver with diffuse hyperechoic
infiltration of liver parenchyma without a well-
demarcated margin. Distortion and compression of
hepatic veins were also identified in addition to intra-
luminal filling of echogenic lesions in the bilateral
intrahepatic portal and main portal veins (Fig. 2).
Within the ill-defined tumor, some echogenic nod-
ules were found and a small amount of ascites was
also detected (Fig. 3). The sonographic findings
suggested infiltrating hepatoma with portal vein
thrombosis. Enhanced CT scans demonstrated a
A B
Fig. 1. (A) Axial non-contrast computed tomography (CT) image shows homogeneous liver parenchyma without focal lesion. 
(B) Axial contrast-enhanced CT image shows well-demonstrated portal vein and its branches without focal hepatic and portal vein lesion.
A B
Fig. 2. (A) Diffuse hyperechoic infiltration of the liver without a well-demarcated margin with distorted and compressed left
hepatic vein (arrow head), and thrombosed intrahepatic portal vein (arrow) (subcostal section). (B) Associated thrombus of the
main portal vein: the portal trunk has a solid lumen (intercostal section).
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well-marginated hypo-enhancing tumor occupy-
ing nearly the entire left lobe and the anterior seg-
ment of right lobe of the liver, in addition to portal
vein thrombosis (Fig. 4). These findings were again
highly suspicious for infiltrating hepatoma with
portal vein thrombosis. CT-guided fine needle
biopsy was performed due to the clinical contro-
versy of possible hepatoma with portal vein
thrombosis suggested by the imaging studies and
her past history of chronic hepatitis C, despite a
prominent elevation of CEA level strongly sugges-
tive of colon carcinoma with liver metastasis. The
liver biopsy revealed metastatic adenocarcinoma,
composed of neoplastic cells arranged in irregular
tubular and complex glandular structures (Fig. 5),
morphologically similar to the previous colonic
adenocarcinoma (Fig. 6). Based on the pathologi-
cal findings, colon carcinoma with liver metastasis
was finally diagnosed. On March 27, 2006, the
patient died of acute hepatic failure.
Discussion
In patients with colon carcinoma without 
apparent liver metastasis at the time of surgery
A B
Fig. 3. (A) Diffuse hyperechoic infiltration of liver as well as two relatively hyperechoic nodules within the tumor (arrows) (right
intercostal section). (B) No splenomegaly, spleen surrounded by minimal ascites (left intercostal section).
Fig. 4. Axial contrast-enhanced computed tomography image
shows a well-marginated hypo-enhancing tumor occupying
nearly the entire left hepatic lobe which extends into the right
lobe with tumor thrombus in the main portal vein.
Fig. 5. Histology of metastatic adenocarcinoma in liver. This
specimen contains components of both hepatocytes (H) and
colon carcinoma (CC) (hematoxylin and eosin, ×400).
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who subsequently develop liver metastasis, the pri-
mary liver metastasis is considered to have devel-
oped about two years prior to the surgery, based
on calculations of the tumor doubling time. In
addition, the proliferation of micrometastases is in-
hibited by vessel inhibition factors excreted by the
primary tumor. After removal of the primary tumor,
the growth of the previously silent micrometas-
tases is then activated [1]. Thomas et al [2] studied
liver tissues removed from cancer patients, and ultra-
sonography performed ex vivo was able to detect
95% of tumors with a dimension greater than
10 mm but did not detect any of the tumors mea-
suring 5 mm in dimension. In our case, the patient
suffered from advanced colon carcinoma with liver
metastasis and portal vein thrombosis a mere 
5 months after surgical intervention in spite of a
negative study in the previous preoperative liver
CT scans. In fact, micrometastases to the liver could
have already occurred before surgical intervention.
The most common primary sites leading to liver
metastases are colon, pancreas, stomach, breast
and lung. Metastases are most frequently multiple;
however, solitary metastatic lesions can be seen.
Sonographic patterns of metastases include a tar-
get pattern, hypoechoic, isoechoic, hyperechoic,
calcified, cystic, and diffuse patterns. The diffuse
type of metastatic disease distorts the parenchyma
throughout the liver and sonographically produces
a diffusely inhomogeneous echo pattern which may
be difficult to differentiate from cirrhosis [3]. Sono-
graphically, the appearance of hepatoma is variable.
The masses may be hypoechoic, hyperechoic, or of
mixed echogenicity [4], and may be solitary, multi-
ple, or less frequently (7–10%), diffusely infiltrating,
thereby distorting the liver architecture [5]. Tumor
thrombosis is most frequently seen secondary to
hepatoma (in 30–70% of patients with hepatoma)
and much less frequently in metastatic liver disease
(in 5–8% of patients with diffuse liver metastases)
[6]. Gastric and colonic cancers are the most com-
mon primary sources of hepatic metastasis with
portal vein thrombosis. According to the 1997
Annual of Pathological Autopsy Cases in Japan, the
incidence of portal vein metastasis in gastric can-
cer, and in colon and rectal cancer, was reported
to be 1.2% (29/2,330) and 0.6% (9/1,604), respec-
tively [7]. In general, portal vein tumor thrombosis
is a common finding and a significant negative
prognostic indicator in hepatocellular carcinoma [8].
In patients with colorectal liver metastases, macro-
scopic portal vein tumor thrombosis is rare and has
been reported to occur in 2.8% of cases [9]. The
outcome in these patients, however, was favorable
relative to patients with hepatocellular carcinoma
with portal vein tumor thrombosis [9,10]. Conse-
quently, a misleading diagnosis made by abdominal
echogram could result in a completely different
and inappropriate treatment modality and life
expectancy for the patient. In our case, abdominal
ultrasonography revealed a diffuse infiltrating echo
pattern of liver parenchyma, distortion and com-
pression of intrahepatic veins, and most importantly
portal vein thrombosis, all of which helped us make
an initial diagnosis of suspected infiltrating hepa-
toma with portal vein thrombosis instead of colon
carcinoma with liver metastasis. On CT scans, 
the well-marginated hypo-enhancing tumor with
portal vein thrombosis which is more commonly
encountered in hepatoma was detected in this
patient. Unanimously, the initial clinical diagnosis
was hepatoma with portal vein thrombosis accord-
ing to both sonographic and CT imaging studies
and her past history of chronic hepatitis C. In stark
Fig. 6. Histology of primary colonic adenocarcinoma (hema-
toxylin and eosin, ×400).
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contrast, CT guided needle biopsy unexpectedly
revealed metastatic adenocarcinoma, and this
together with a significantly elevated serum CEA
level accompanied by a normal serum level of AFP
further supported the pathological diagnosis.
If the patient (Dukes C; stage III) had received
postoperative adjuvant therapy at that time, treat-
ment with fluorouracil (5-FU) plus levamisole could
have reduced the relative risk of cancer recurrence
by 42%, and the overall death rate by 33% com-
pared with surgery alone [11]. Data on all 929 eli-
gible patients followed for 5 years or more confirm
that 5-FU plus levamisole reduced recurrence rate
by 40% and the death rate by 33% [12]. Other
combined adjuvant chemotherapies for colon 
cancer currently being studied include regimens 
containing oxaliplatin and irinotecan. The use of
combination therapies with either (1) irinotecan,
5-FU/leucovorin, or (2) oxaliplatin, 5-FU/leucovorin
has demonstrated improved response and survival
in advanced colorectal carcinoma [13]. In accordance
with National Comprehensive Cancer Network
Colon Cancer and Rectal Cancer Guidelines (Version
1.2008), 5-FU/leucovorin/oxaliplatin, capecitabine,
or 5-FU/leucovorin are suggested as adjuvant
chemotherapy for treating stage III (Dukes C)
patients [14].
Current treatment modalities for colorectal metas-
tatic liver tumors are hepatic resection, cryotherapy,
radiofrequency ablation, adjuvant chemotherapy,
and the combination of chemotherapy and target
therapy [13]. Radical tumor resection should be
performed when technically possible, even when
the tumor is accompanied by macroscopic biliary
and/or portal vein tumor thrombus [15]. None-
theless, for the treatment of advanced infiltrating
hepatoma with portal vein thrombosis, targeted
therapy such as sorafenib or sunitinib could be the
only promising drugs of choice to extend the pati-
ent’s life span [16,17].
In summary, liver metastasis from colon carci-
noma with portal vein thrombosis could masquer-
ade as infiltrating hepatoma based on abdominal
ultrasonography and enhanced CT scans. To obtain
an authentic diagnosis, particularly in patients with
inconsistent clinical presentations, CT or ultrasono-
graphic guided needle biopsy should be mandatory
to obtain an accurate diagnosis. A correct diagno-
sis of malignant liver tumor is the cornerstone for
appropriate treatment strategies and greatly influ-
ences the prognosis. On the other hand, inappropri-
ate diagnosis could be disastrous for patients.
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